| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.056 | 0.07 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.08 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |